We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

With seven biosimilars currently on the market and 18 biosimilars approved by the FDA as of April 2019, one question is sparking a lot of debate: What should the scientific, or nonproprietary, names ...

During my time as its president and CEO, the Biotechnology Industry Organization (BIO; Washington, DC) has consistently called for open, transparent and science-based dialogue regarding biosimilars.